1256978

Pfizer, Inc. — FEI 3003836868

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 18, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Parsippany, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)